Hormonal treatment of transsexual patients and its metabolic consequences;Le traitement hormonal des patients transsexuels et ses conséquences métaboliques

Annales d'Endocrinologie

Volumn 68, Issue 4, 2007, Pages 258-264

  Corman, V ^a   Legros, J J ^a  

^a Service d'Endocrinologie   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; CYPROTERONE ACETATE; ESTRADIOL; ESTRADIOL VALERATE; ESTROGEN; ETHINYLESTRADIOL; LEPTIN; PROGESTERONE; PROSTATE SPECIFIC ANTIGEN; SPIRONOLACTONE; TESTOCAPS; TESTOSTERONE; TESTOSTERONE UNDECANOATE; UNCLASSIFIED DRUG;

ARTICLE; CHROMOSOME ABERRATION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FOLLOW UP; GENDER IDENTITY; HORMONAL THERAPY; HUMAN; MAMMARY GLAND; MENTAL DISEASE; METABOLIC SYNDROME X; TRANSSEXUALISM; VENOUS THROMBOEMBOLISM; CHEMICALLY INDUCED DISORDER; FEMALE; MALE; METABOLISM; REVIEW; VEIN THROMBOSIS;

ANDROGENS; ESTROGENS; FEMALE; HUMANS; MALE; TRANSSEXUALISM; VENOUS THROMBOSIS;

EID: 34548500374     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ando.2007.06.017     Document Type: Article

References (32)

1. Bisschop P.H., Toorians A.W., Endert E., Wiersinga W.M., Gooren L.J., and Fliers E. The effects of sex-steroid administration on the pituitary-thyroid axis in transsexuals. Eur. J. Endocrinol. 155 (2006) 11-16
2. Casella R., Bubendorf L., Schaefer D., Bachmann A., Gasser T., and Sulser T. Does the prostate really need androgens to growth? Transurethral resection of the prostate in a male-to-female transsexual 25 years after sex-changing operation. Urologia 75 (2005) 288-290
3. Elbers J.M., Asscheman H., Seidell J.C., Frölich M., Meinders E.A., and Gooren L.J. Reversal of the sex difference in serum leptin levels upon cross-sex hormone administration in transsexuals. J. Clin. Endocrinol. Metab. 82 10 (1997) 3267-3270
4. Elbers J.M., Asscheman H., Seidell J.C., and Gooren L.J. Effects of sex steroid hormones on regional fat depots as assessed by magnetic resonance imaging in transsexuals. Am. J. Physiol. 276 (1999) E317-E325
5. Elbers J.M., Giltay E.J., Teerlink T., et al. Effects of sex steroids on components of the insulin resistance syndrome in transsexual subjects. Clin. Endocrinol. (Oxf.) 58 (2003) 562-571
6. Futterweit W. Endocrine therapy of transsexualism and potential complications of long-term treatment. Arch. Sex. Behav. 27 2 (1998) 209-226
7. Giltay E.J., Gooren L.J., Emeis J.J., Kooistra T.I., and Stehouwer C.L. Oral, but not transdermal, administration of estrogens lowers tissue-type plasminogen activator levels in humans without affecting endothelial synthesis. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 1396-1403
8. Giltay E.J., Hoogeveen E.K., Elbers J.M., Gooren L.J., Asscheman H., and Stehouwer C.D. Effects of sex steroids on plasma total homocysteine levels: a study in transsexual males and females. J. Clin. Endocrinol. Metab. 83 2 (1998) 550-553
9. Goh H.H., and Ratnam S.S. Effects of hormone deficiency, androgen therapy and calcium supplementation on bone mineral density in female transsexuals. Maturitas- Journal of the Climacteric and Postmenopause 26 (1997) 45-52
10. Gooren L.J. Hormone treatment of the adult transsexual patient. Horm. Res. 64 suppl 2 (2005) 31-36
11. Haraldsen I.R., Egeland T., Haug E., Finset A., and Opjordsmoen S. Cross-sex hormone treatment does not change sex-sensitive cognitive performance in gender identity disorder patients. Psychiatry Res. 137 (2005) 161-174
12. Henningsson S., Westberg L., Nilsson S., et al. Sex steroid-related genes and male-to-female transsexualism. Psychoneuroendocrinology 30 (2005) 657-664
13. Ho K.K., O'Sullivan A.J., Wolthers T., and Leung K.C. Metabolic effects of estrogens: impact of the route of administration. Ann. Endocrinol. (Paris) 64 2 (2003) 170-177
14. Jin B., Turner L., Walters W.A., and Handelsman D.J. Androgen or estrogen on human prostate. J. Clin. Endocrinol. Metab. 81 12 (1996) 4290-4295
15. Kruijver F.P., Fernandez-Guasti A., Fodor M., Kraan E., and Swaab D. Sex differences in androgen receptors of the human mamillary bodies are related to endocrine status rather than to sexual orientation or transsexuality. J. Clin. Endocrinol. Metab. 86 2 (2000) 818-827
16. Levy A., Crown A., and Reid R. Endocrine intervention for transsexuals. Clin. Endocrinol. (Oxf.) 59 (2003) 409-418
17. Lips P., Van Kesteren P.J., Asscheman H., and Gooren L.J. The effect of androgen treatment on bone metabolism in female-to-male transsexuals. J. Bone Miner. Res. 11 11 (1996) 1769-1773
18. Lissett C.A., and Shalet S.M. The impact of dose and route of estrogen administration on the somatotropic axis in normal women. J. Clin. Endocrinol. Metab. 88 10 (2003) 4668-4672
19. Michel A., Mormont C., and Legros J.J. A psycho-endocrinological overview of transsexualism. Eur. J. Endocrinol. 145 (2001) 365-376
20. Miles C., Green R., Sanders G., and Hines M. Estrogen and memory in a transsexual population. Horm. Behav. 34 (1998) 199-208
21. Reutrakul S., Ongphiphadhanakul B., Piaseu N., et al. The effects of estrogen exposure on bone mass in male to female transsexuals. Clin. Endocrinol. (Oxf.) 49 (1998) 811-814
22. Rodriguez-Rigau L.J., Tcholakian R.K., Smith K.D., and Steinberger E. In vitro steroid metabolic studies in human testes: effects of estrogen on progesterone metabolism. Steroids 29 6 (1977) 771-786
23. Scarabin P.Y., Oger E., and Plu-Bureau G. Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk. Lancet 363 (2003) 428-432
24. Slabbekoorn D., van Goozen S.H., Megens J., Gooren L.J., and Cohen-Kettenis P.T. Activating effects of cross-sex hormones on cognitive functioning: a study of short-term and long-term hormone effects in transsexuals. Psychoneuroendocrinology 24 (1999) 423-447
25. Sosa M., Jódar E., Arbelo E., et al. Serum lipids and estrogen receptor gene polymorphism in male-to-female transsexuals: effects of estrogen treatment. European Journal of Internal Medicine 15 (2004) 231-237
26. Van Kesteren P.J., Asscheman H., Megens J.A., and Gooren L.J. Mortality and morbidity in transsexual subjects treated with cross-sex hormones. Clin. Endocrinol. (Oxf.) 47 (1997) 337-342
27. Van Kesteren P.J., Lips P., Deville W., et al. The effect of one-year cross-sex hormonal treatment on bone metabolism and serum insulin-like growth factor-1 in transsexuals. J. Clin. Endocrinol. Metab. 81 6 (2006) 2227-2232
28. Van Kesteren P.J., Lips P., Gooren L.J., Asscheman H., and Megens J. Long-term follow-up of bone mineral density and bone metabolism in transsexuals treated with cross-sex hormones. Clin. Endocrinol. (Oxf.) 48 (1998) 347-354
29. Veldhuis J.D., Anderson S.M., Kok P., et al. Estradiol supplementation modulates growth hormone (GH) secretory-burst waveform and recombinant human insulin-like growth factor-1- enforced suppression of endogenously driven GH release in postmenopausal women. J. Clin. Endocrinol. Metab. 89 3 (2004) 1312-1318
30. Veldhuis J., Evans W., Iranmanesh A., Weltman A., and Bowers C. Short-term testosterone supplementation relieves growth hormone autonegative feedback in men. J. Clin. Endocrinol. Metab. 89 3 (2004) 1285-1290
31. Wilson R., Jenkins C., Miller H., and Carr S. The effects of estrogen on cytokine and antioxydant levels in male to female transsexual patients. J. Maturitas. (2006) (In press)
32. Yan M., Jones M.E., Hernandez M., Liu D., Simpson E.R., and Chen C. Functional modification of pituitary somatotropes in the aromatase knockout mouse and the effect of estrogen replacement. Endocrinology 145 2 (2004) 604-612